Vyant Bio, Inc.
NASDAQ: VYNT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Andrew D.C. LaFrence CPA
- Employees
- 4
- Headquarters
- Cherry Hill, United States
- IPO year
- 2021
- Website
- https://www.vyantbio.com
Loading VYNT…
Loading profile data…Frequently asked questions about VYNT
What does Vyant Bio, Inc. (VYNT) do?
Vyant Bio, Inc. is a biotechnology company focused on identifying treatments for intricate neurological conditions, including both neurodevelopmental and neurodegenerative disorders. The firm leverages a sophisticated central nervous system (CNS) drug discovery platform that integrates human-derived brain organoid models, high-throughput biologi...
Where does VYNT trade?
Vyant Bio, Inc. (VYNT) trades on the NASDAQ Capital Market.
What sector is VYNT in?
Vyant Bio, Inc. (VYNT) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Vyant Bio, Inc.?
Andrew D.C. LaFrence CPA is the chief executive officer of Vyant Bio, Inc. (VYNT).
Where is Vyant Bio, Inc. headquartered?
Vyant Bio, Inc. is headquartered in United States.
Does VYNT pay a dividend?
Vyant Bio, Inc. (VYNT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VYNT go public?
Vyant Bio, Inc. (VYNT) completed its initial public offering in 2021.